Endomysial Antibodies IgG (EMA) Test
Pinpoint the autoimmune driver of gluten sensitivity.
The Endomysial Antibodies IgG (EMA) test is a specialist blood test used to detect a specific autoantibody associated with coeliac disease, an immune-mediated condition triggered by gluten. It is particularly valuable for individuals who have persistent gastrointestinal symptoms, unexplained nutrient deficiencies, or a family history of coeliac disease, and for those who cannot undergo standard IgA-based testing due to IgA deficiency. This test measures IgG-class endomysial antibodies, which target the connective tissue surrounding smooth muscle fibres in the gut. The presence of these antibodies strongly suggests active coeliac disease and can help guide further clinical evaluation.
Biomarkers
- Endomysial Antibodies IgG (EMA)
Why it matters
Early identification of coeliac disease through EMA IgG testing allows for timely dietary intervention, which can alleviate symptoms, heal intestinal damage, and prevent long-term complications such as malnutrition and osteoporosis. For individuals with IgA deficiency, this test offers a reliable alternative when standard IgA-based screening is inconclusive.
- Endomysial Antibodies IgG (EMA)
No special preparation required.
For blood tests, we recommend drinking plenty of water beforehand to ensure smooth sample collection. If you are taking any regular medication, continue to do so unless advised otherwise by your doctor.
Important Clinical Information:
This test is a screening tool to monitor and support your overall health. It does not replace your GP or Consultant.
Always discuss your test results, especially any abnormal results, with your GP, who can interpret them in the context of your medical history and overall health.
Service Booking
Includes £15 phlebotomy fee
View My Booking